Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial
Jenks K, Stebbings S, Burton J, Schultz M, Herbison P, Highton J
Published in Journal of Rheumatology
Methodology
Randomised double-blind placebo-controlled trial of a multi-strain probiotic for 12 weeks in patients with spondyloarthritis including ankylosing spondylitis.
Key Findings
No significant differences were found between probiotic and placebo groups in BASDAI, BASFI or quality-of-life measures.
Conclusions
Probiotic therapy did not improve symptoms in spondyloarthritis despite the gut-joint hypothesis.
Limitations
Twelve-week duration; single probiotic formulation; modest sample size.
Supplements Studied
Probiotic therapy produced no significant improvement in BASDAI, BASFI or quality of life in spondyloarthritis.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.